U.S. markets open in 3 hours 9 minutes

Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1139+0.0018 (+1.61%)
At close: 2:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.1121
Open0.1114
BidN/A x N/A
AskN/A x N/A
Day's Range0.1110 - 0.1139
52 Week Range0.0088 - 0.1973
Volume2,718
Avg. Volume54,141
Market Cap82.332M
Beta (5Y Monthly)1.90
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Investors Who Bought Cannara Biotech (CVE:LOVE) Shares A Year Ago Are Now Up 113%
      Simply Wall St.

      Investors Who Bought Cannara Biotech (CVE:LOVE) Shares A Year Ago Are Now Up 113%

      When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...

    • Cannara Virtually Closes The Market
      CNW Group

      Cannara Virtually Closes The Market

      Nicholas Sosiak, Chief Financial Officer, Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) and his team joined Berk Sumen, Head, Company Services, TMX Group, to celebrate the Company's new listing on TSX Venture Exchange and close the market.

    • Cannara Biotech Commences Trading on TSXV on April 8, 2021
      CNW Group

      Cannara Biotech Commences Trading on TSXV on April 8, 2021

      Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade indoor cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced its common shares will be listed on the TSX Venture Exchange (the "TSXV"). The common shares of the Company will commence trading on TSXV at the opening on Thursday, April 8, 2021. The Company is presently trading on the Canadian Stock Exchange ("CSE"). At the commencement of trading on the TSXV, the securities of the Company will be delisted from the CSE with no resulting change to the Company's ticker (LOVE).